Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076605 · ClinicalTrials.gov registry record
Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 1,182
- Enrollment target
NCT04076605: Completed study, sponsored by University of Virginia.
NCT04076605 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 1,182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04076605 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 1,182 participants
- Enrollment target
Study Summary
Patients with cirrhosis are frequently hospitalized and often undergo procedures. Knowledge surrounding bleeding risk is sparse and practice patterns vary across centers in regards to bleeding prophylaxis. The goal of this study to is to obtain more knowledge regarding risk factors for procedural related bleeding in patients with cirrhosis and to develop a predictive model to risk stratify patients before undergoing procedures. Through collaboration from centers across the world this study should provide information on prevalence of bleeding and variation in practice patterns for prophylaxis.
Primary Outcome
During each hospitalization every procedure will be recorded and details surrounding each bleeding event related to a procedure will be recorded.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,182 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2022-07-29 |
What the finished NCT04076605 record still lists
NCT04076605 is an observational study that tracks outcomes without assigning an intervention. Its 1,182 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04076605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04076605 about?
NCT04076605 is a clinical study titled "Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures". Patients with cirrhosis are frequently hospitalized and often undergo procedures. Knowledge surrounding bleeding risk is sparse and practice patterns vary across centers in regards to bleeding prophylaxis. The goal of this study to is to obtain more knowledge regarding risk factors for procedural re...
What is the current status of trial NCT04076605?
This trial is currently completed. The enrollment target is 1,182 participants. The study started on 2019-11-15. Estimated completion is 2022-07-29.
Who is sponsoring clinical trial NCT04076605?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05688436 · 1,178 participants
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- NCT06931275 · 1,178 participants · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI